Briggs Morrison - Jan 14, 2022 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Briggs Morrison
Stock symbol
ARVN
Transactions as of
Jan 14, 2022
Transactions value $
-$1,115,013
Form type
4
Date filed
1/19/2022, 08:00 PM
Previous filing
Dec 20, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Options Exercise $259K +16.2K +54.84% $16.00 45.7K Jan 14, 2022 Direct F1
transaction ARVN Common Stock Sale -$638K -9.92K -21.7% $64.33 35.8K Jan 14, 2022 Direct F1, F2
transaction ARVN Common Stock Sale -$250K -3.83K -10.71% $65.24 32K Jan 14, 2022 Direct F1, F3
transaction ARVN Common Stock Sale -$343K -5.1K -15.96% $67.28 26.9K Jan 14, 2022 Direct F1, F4
transaction ARVN Common Stock Sale -$143K -2.11K -7.85% $67.69 24.7K Jan 14, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARVN Stock Option (right to buy) Options Exercise $0 -16.2K -49.25% $0.00 16.7K Jan 14, 2022 Common Stock 16.2K $16.00 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.9000 to $64.8800, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.9200 to $65.8900, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, the number of shares sold at each separate price within the range set forth in this footnote (3).
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.5300 to $67.5200, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, the number of shares sold at each separate price within the range set forth in this footnote (4).
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.5400 to $67.9600, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, the number of shares sold at each separate price within the range set forth in this footnote (5).
F6 This option award was granted on September 26, 2018. 1/12 of the shares underlying the award vested as of June 28, 2018, with the remainder of the shares vesting in equal quarterly installments following June 28, 207 through March 28, 2021.